Directory
>
Elisabeth Leiderman Md
Elisabeth Leiderman Md
Chief Financial Officer & Corporate Development Officer | Women In Bio - Engage. Educate. Empower.
New York, New York, United States
Elisabeth Leiderman Md
Summary
Elisabeth Leiderman is a distinguished finance executive and medical doctor with over 20 years of experience in the biotechnology and investment sectors. She has held pivotal roles such as Chief Financial Officer and Chief Business Officer at Atsena Therapeutics, where she contributed to innovative gene therapy developments. Dr. Leiderman's extensive background includes senior positions in healthcare investment banking, providing strategic insights for biopharma companies. She is recognized for her ability to navigate complex business landscapes, leveraging her medical expertise to drive corporate growth. An alumnus of the Wharton School, she holds an MBA, an MD from Tel Aviv University, and a BA in Biological Sciences. Elisabeth is actively involved in board roles, including serving as Audit Committee Chair at Bluebird Bio, showcasing her commitment to corporate governance. Her unique blend of finance and healthcare knowledge positions her as a key player in advancing life sciences.
Elisabeth Leiderman Md
Work Experience
Chief Financial Officer & Corporate Development Officer at
Dewpoint Therapeutics
June 2024 - Present
Board of Directors and Audit Committee Member at
Autolus Therapeutics
December 2023 - Present
Board of Directors and Audit Committee Chair at
bluebird bio
October 2021 - Present
Executive Women in Bio 2019 Board Room Ready Member at
Women In Bio - Engage. Educate. Empower.
September 2019 - Present
Chief Financial Officer & Chief Business Officer at
Atsena Therapeutics
January 2022 - January 2023
Chief Financial Officer & Head of Corporate Development at
Decibel Therapeutics
January 2020 - January 2022
Chief Business Officer at
Complexa Inc.
January 2020 - September 2020
Senior Vice President, Head of Corporate Development at
Fortress Biotech
January 2016 - January 2019
Executive Director, Healthcare Investment Banking at
Nomura
January 2013 - January 2016
Vice President, Healthcare Investment Banking at
Credit Suisse
January 2011 - January 2013
Associate, Healthcare Investment Banking at
Jefferies
January 2009 - January 2011
Associate Director, Healthcare Investment Banking at
UBS
January 2007 - January 2009
Elisabeth Leiderman Md
Education
Wharton School, Mba
January 2005 - January 2007
American Medical Program Tel Aviv University, Md
January 1999 - January 2003
University of Pennsylvania, Ba
January 1994 - January 1998
Frequently Asked Questions about Elisabeth Leiderman Md
What is Elisabeth Leiderman Md email address?
Elisabeth Leiderman Md's primary email address is **********@womeninbio.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Elisabeth Leiderman Md work for?
Elisabeth Leiderman Md is a Chief Financial Officer & Corporate Development Officer at Women In Bio - Engage. Educate. Empower., a company specializing in Business, Professional, Labor, Political, & Similar Organizations .
Where Elisabeth Leiderman Md graduated from?
Elisabeth Leiderman Md holds a degree in Finance And Healthcare Management from Wharton School.
How can I directly contact Elisabeth Leiderman Md?
To contact Elisabeth Leiderman Md directly, you can use the email address **********@womeninbio.org. Complete contact information is available upon registration with Muraena.
Is Elisabeth Leiderman Md an immigrant?
Yes, Elisabeth Leiderman Md is an immigrant and currently based in United States
Who is Elisabeth Leiderman Md?
Elisabeth Leiderman is a distinguished finance executive and medical doctor with over 20 years of experience in the biotechnology and investment sectors. She has held pivotal roles such as Chief Financial Officer and Chief Business Officer at Atsena Therapeutics, where she contributed to innovative gene therapy developments. Dr. Leiderman's extensive background includes senior positions in healthcare investment banking, providing strategic insights for biopharma companies. She is recognized for her ability to navigate complex business landscapes, leveraging her medical expertise to drive corporate growth. An alumnus of the Wharton School, she holds an MBA, an MD from Tel Aviv University, and a BA in Biological Sciences. Elisabeth is actively involved in board roles, including serving as Audit Committee Chair at Bluebird Bio, showcasing her commitment to corporate governance. Her unique blend of finance and healthcare knowledge positions her as a key player in advancing life sciences.
Elisabeth`s contact details
**********@womeninbio.org
*********@bluebirdbio.com
Colleagues
Senior Director Corporate & Portfolio Operations
Chair -RTP Chapter
Advisor
Alumni Board of Directors
Director, Institutional Partnerships
Principal
Executive Director
Board Member
Seattle Chapter Vice Chair & Board Member
Venture Partner